Not available for delivery
Prescription Medicines SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO. LTD (SAJA), SAUDI ARABIABetmiga 50mg 30 Tablets
Product specifications
- Active ingredient
- Mirabegron
- Strength
- 50 MG
- Dosage form
- PROLONGED RELEASE TABLETS
- Size
- 30'S
- Manufacturer
- SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO. LTD (SAJA), SAUDI ARABIA
- Barcode
- 06285094000899
Product description
About this product
Betmiga 50 mg are prolonged-release tablets, 30 per pack, with mirabegron as the active ingredient, from the Saudi Arabian Japanese Pharmaceutical Co. They are dispensed on prescription.
Benefits and uses
- The source describes a beta-3 agonist associated with overactive bladder
- Indication as per the leaflet
How to use
The source mentions one tablet by mouth once daily, with or without food, swallowed whole; dose as per the leaflet or doctor.
Ingredients and strength
Mirabegron 50 mg in a prolonged-release tablet; inactive ingredients are listed on the pack.
Warnings
- The source notes it may raise blood pressure, so hypertensive patients need monitoring
- Caution in severe liver or kidney disease
- Not for use in children
Storage
Keep out of reach of children as printed on the pack.
Dispensed on prescription only. This information is general and does not replace advice from your doctor or pharmacist.
For best use, consult the pharmacist.